{"id":31938,"date":"2020-11-09T08:58:26","date_gmt":"2020-11-09T13:58:26","guid":{"rendered":"https:\/\/dev.inrs.ca\/?p=31938"},"modified":"2020-11-09T09:01:34","modified_gmt":"2020-11-09T14:01:34","slug":"bringing-drugs-to-the-brain-with-nanoparticles-to-treat-neurodegenerative-diseases","status":"publish","type":"post","link":"https:\/\/dev.inrs.ca\/en\/news\/bringing-drugs-to-the-brain-with-nanoparticles-to-treat-neurodegenerative-diseases\/","title":{"rendered":"Bringing drugs to the brain with nanoparticles to treat neurodegenerative diseases"},"content":{"rendered":"

Researchers from the Institut national de la recherche scientifique (INRS) have shown that nanoparticles could be used to deliver drugs to the brain to treat neurodegenerative diseases.<\/strong><\/p>\n

The blood-brain barrier is the main obstacle in treating neurodegenerative diseases such as Alzheimer and Parkinson. According to a recent study<\/a> conducted by Jean-Michel Rabanel, a postdoctoral researcher under the supervision of Professor Charles Ramassamy<\/a>, nanoparticles with specific properties could cross this barrier and be captured by neuronal cells. Researchers are confident that these results will open important prospects for releasing drugs directly to the brain. This breakthrough finding would enable improved treatment for neurodegenerative diseases affecting more than 565,000 Canadians, including 141,000 Quebecers.

<\/p>\n

\"\"
Professor Charles Ramassamy and Jean-Michel Rabanel analyzing nanoparticles on the Nanosight NS 300, equipment obtained thanks to the generosity of the Charron family through the Armand-Frappier Foundation as part of the Louise & Andr\u00e9 Charron research chair on the Alzheimer’s disease.<\/figcaption><\/figure>\n


“The blood-brain barrier filters out harmful substances to prevent them from freely reaching the brain. But this same barrier also blocks the passage of drugs,” explains the pharmacologist Charles Ramassamy. Typically, high doses are required to get a small amount of the drug into the brain. What remains in the bloodstream has significant side effects. Often, this discomfort leads the patient to stop the treatment. \u2009The use of nanoparticles, which encapsulate the drugs, would result in fewer collateral side effects while increasing brain efficiency.<\/p>\n

Efficient on an animal model<\/strong><\/h3>\n

To prove the effectiveness of this method, the research team first tested it on cultured cells, then on zebrafish. “This species offers several advantages. Its blood-brain barrier is similar to that of humans and its transparent skin makes it possible to see nanoparticles’ distribution almost in real time,” says Professor Ramassamy, Chairholder of the Louise and Andr\u00e9 Charron Research Chair on Alzheimer’s disease<\/a>, from the Fondation Armand-Frappier.<\/p>\n

Using in vivo <\/em>tests, researchers were able to observe the crossing of the blood-brain barrier. They also confirmed the absence of toxicity in the library of selected nanoparticles. “We made the particles with polylactic acid (PLA), a biocompatible material that is easily eliminated by the body. A layer of polyethylene glycol (PEG) covers these nanoparticles and makes them invisible to the immune system, so they can longer circulate in the bloodstream,” he explains.<\/p>\n

\"\"<\/p>\n

After several years of research on effective and safe nanoparticles, the research team will continue laboratory testing, targeting the delivery of active ingredients to other animal models with ultimate clinical applications.<\/p>\n


About this study<\/strong><\/h3>\n

The article “Transport of PEGylated-PLA nanoparticles across a blood brain barrier model, entry into neuronal cells and in vivo<\/em> brain bioavailability” was published in September 2020 in the renowned Journal of Controlled Release<\/em>. The research team received financial support from the Natural Sciences and Engineering Research Council of Canada (NSERC), the Fonds de recherche du Qu\u00e9bec – Nature et technologies (FRQNT), the Fonds de recherche du Qu\u00e9bec – Sant\u00e9 (FRQS), the Canada Foundation for Innovation (CFI) and the Fondation Armand-Frappier (Louise and Andr\u00e9 Charron Research Chair in Alzheimer’s Disease).<\/p>\n

https:\/\/doi.org\/10.1016\/j.jconrel.2020.09.042<\/a><\/p>\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Researchers from INRS have shown that nanoparticles could be used to deliver drugs to the brain to treat neurodegenerative diseases.<\/p>\n","protected":false},"author":4,"featured_media":31955,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[688],"tags":[],"sectors":[679],"class_list":["post-31938","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-innover-a-linrs-en","sectors-sante-en"],"acf":[],"yoast_head":"\nBringing drugs to the brain with nanoparticles to treat neurodegenerative diseases | INRS<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bringing drugs to the brain with nanoparticles to treat neurodegenerative diseases | INRS\" \/>\n<meta property=\"og:description\" content=\"Researchers from INRS have shown that nanoparticles could be used to deliver drugs to the brain to treat neurodegenerative diseases.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dev.inrs.ca\/en\/news\/bringing-drugs-to-the-brain-with-nanoparticles-to-treat-neurodegenerative-diseases\/\" \/>\n<meta property=\"og:site_name\" content=\"INRS\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/inrsciences\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-09T13:58:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-11-09T14:01:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/dev.inrs.ca\/wp-content\/uploads\/2020\/11\/20201106_152123.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1300\" \/>\n\t<meta property=\"og:image:height\" content=\"726\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Anne-Marie Dubois\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@inrsciences\" \/>\n<meta name=\"twitter:site\" content=\"@inrsciences\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anne-Marie Dubois\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/dev.inrs.ca\/en\/news\/bringing-drugs-to-the-brain-with-nanoparticles-to-treat-neurodegenerative-diseases\/\",\"url\":\"https:\/\/dev.inrs.ca\/en\/news\/bringing-drugs-to-the-brain-with-nanoparticles-to-treat-neurodegenerative-diseases\/\",\"name\":\"Bringing drugs to the brain with nanoparticles to treat neurodegenerative diseases | INRS\",\"isPartOf\":{\"@id\":\"https:\/\/dev.inrs.ca\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/dev.inrs.ca\/en\/news\/bringing-drugs-to-the-brain-with-nanoparticles-to-treat-neurodegenerative-diseases\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/dev.inrs.ca\/en\/news\/bringing-drugs-to-the-brain-with-nanoparticles-to-treat-neurodegenerative-diseases\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/dev.inrs.ca\/wp-content\/uploads\/2020\/11\/20201106_152123.jpg\",\"datePublished\":\"2020-11-09T13:58:26+00:00\",\"dateModified\":\"2020-11-09T14:01:34+00:00\",\"author\":{\"@id\":\"https:\/\/dev.inrs.ca\/en\/#\/schema\/person\/230fbba88cd7ef7419094aca351e82cd\"},\"breadcrumb\":{\"@id\":\"https:\/\/dev.inrs.ca\/en\/news\/bringing-drugs-to-the-brain-with-nanoparticles-to-treat-neurodegenerative-diseases\/#breadcrumb\"},\"inLanguage\":\"en-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/dev.inrs.ca\/en\/news\/bringing-drugs-to-the-brain-with-nanoparticles-to-treat-neurodegenerative-diseases\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-CA\",\"@id\":\"https:\/\/dev.inrs.ca\/en\/news\/bringing-drugs-to-the-brain-with-nanoparticles-to-treat-neurodegenerative-diseases\/#primaryimage\",\"url\":\"https:\/\/dev.inrs.ca\/wp-content\/uploads\/2020\/11\/20201106_152123.jpg\",\"contentUrl\":\"https:\/\/dev.inrs.ca\/wp-content\/uploads\/2020\/11\/20201106_152123.jpg\",\"width\":1300,\"height\":726},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/dev.inrs.ca\/en\/news\/bringing-drugs-to-the-brain-with-nanoparticles-to-treat-neurodegenerative-diseases\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"INRS\",\"item\":\"https:\/\/dev.inrs.ca\/linrs\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Newsroom\",\"item\":\"https:\/\/dev.inrs.ca\/linrs\/salle-de-nouvelles\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News\",\"item\":\"https:\/\/dev.inrs.ca\/linrs\/salle-de-nouvelles\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Bringing drugs to the brain with nanoparticles to treat neurodegenerative diseases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/dev.inrs.ca\/en\/#website\",\"url\":\"https:\/\/dev.inrs.ca\/en\/\",\"name\":\"INRS\",\"description\":\"Institut national de la recherche scientifique\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/dev.inrs.ca\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-CA\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/dev.inrs.ca\/en\/#\/schema\/person\/230fbba88cd7ef7419094aca351e82cd\",\"name\":\"Anne-Marie Dubois\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-CA\",\"@id\":\"https:\/\/dev.inrs.ca\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a873465f3292c45cba639ce2f6c6d641?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a873465f3292c45cba639ce2f6c6d641?s=96&d=mm&r=g\",\"caption\":\"Anne-Marie Dubois\"},\"url\":\"https:\/\/dev.inrs.ca\/en\/author\/anne-marie-dubois\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Bringing drugs to the brain with nanoparticles to treat neurodegenerative diseases | INRS","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Bringing drugs to the brain with nanoparticles to treat neurodegenerative diseases | INRS","og_description":"Researchers from INRS have shown that nanoparticles could be used to deliver drugs to the brain to treat neurodegenerative diseases.","og_url":"https:\/\/dev.inrs.ca\/en\/news\/bringing-drugs-to-the-brain-with-nanoparticles-to-treat-neurodegenerative-diseases\/","og_site_name":"INRS","article_publisher":"https:\/\/www.facebook.com\/inrsciences\/","article_published_time":"2020-11-09T13:58:26+00:00","article_modified_time":"2020-11-09T14:01:34+00:00","og_image":[{"width":1300,"height":726,"url":"https:\/\/dev.inrs.ca\/wp-content\/uploads\/2020\/11\/20201106_152123.jpg","type":"image\/jpeg"}],"author":"Anne-Marie Dubois","twitter_card":"summary_large_image","twitter_creator":"@inrsciences","twitter_site":"@inrsciences","twitter_misc":{"Written by":"Anne-Marie Dubois","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/dev.inrs.ca\/en\/news\/bringing-drugs-to-the-brain-with-nanoparticles-to-treat-neurodegenerative-diseases\/","url":"https:\/\/dev.inrs.ca\/en\/news\/bringing-drugs-to-the-brain-with-nanoparticles-to-treat-neurodegenerative-diseases\/","name":"Bringing drugs to the brain with nanoparticles to treat neurodegenerative diseases | INRS","isPartOf":{"@id":"https:\/\/dev.inrs.ca\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/dev.inrs.ca\/en\/news\/bringing-drugs-to-the-brain-with-nanoparticles-to-treat-neurodegenerative-diseases\/#primaryimage"},"image":{"@id":"https:\/\/dev.inrs.ca\/en\/news\/bringing-drugs-to-the-brain-with-nanoparticles-to-treat-neurodegenerative-diseases\/#primaryimage"},"thumbnailUrl":"https:\/\/dev.inrs.ca\/wp-content\/uploads\/2020\/11\/20201106_152123.jpg","datePublished":"2020-11-09T13:58:26+00:00","dateModified":"2020-11-09T14:01:34+00:00","author":{"@id":"https:\/\/dev.inrs.ca\/en\/#\/schema\/person\/230fbba88cd7ef7419094aca351e82cd"},"breadcrumb":{"@id":"https:\/\/dev.inrs.ca\/en\/news\/bringing-drugs-to-the-brain-with-nanoparticles-to-treat-neurodegenerative-diseases\/#breadcrumb"},"inLanguage":"en-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dev.inrs.ca\/en\/news\/bringing-drugs-to-the-brain-with-nanoparticles-to-treat-neurodegenerative-diseases\/"]}]},{"@type":"ImageObject","inLanguage":"en-CA","@id":"https:\/\/dev.inrs.ca\/en\/news\/bringing-drugs-to-the-brain-with-nanoparticles-to-treat-neurodegenerative-diseases\/#primaryimage","url":"https:\/\/dev.inrs.ca\/wp-content\/uploads\/2020\/11\/20201106_152123.jpg","contentUrl":"https:\/\/dev.inrs.ca\/wp-content\/uploads\/2020\/11\/20201106_152123.jpg","width":1300,"height":726},{"@type":"BreadcrumbList","@id":"https:\/\/dev.inrs.ca\/en\/news\/bringing-drugs-to-the-brain-with-nanoparticles-to-treat-neurodegenerative-diseases\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"INRS","item":"https:\/\/dev.inrs.ca\/linrs\/"},{"@type":"ListItem","position":2,"name":"Newsroom","item":"https:\/\/dev.inrs.ca\/linrs\/salle-de-nouvelles\/"},{"@type":"ListItem","position":3,"name":"News","item":"https:\/\/dev.inrs.ca\/linrs\/salle-de-nouvelles\/actualites\/"},{"@type":"ListItem","position":4,"name":"Bringing drugs to the brain with nanoparticles to treat neurodegenerative diseases"}]},{"@type":"WebSite","@id":"https:\/\/dev.inrs.ca\/en\/#website","url":"https:\/\/dev.inrs.ca\/en\/","name":"INRS","description":"Institut national de la recherche scientifique","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.inrs.ca\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-CA"},{"@type":"Person","@id":"https:\/\/dev.inrs.ca\/en\/#\/schema\/person\/230fbba88cd7ef7419094aca351e82cd","name":"Anne-Marie Dubois","image":{"@type":"ImageObject","inLanguage":"en-CA","@id":"https:\/\/dev.inrs.ca\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a873465f3292c45cba639ce2f6c6d641?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a873465f3292c45cba639ce2f6c6d641?s=96&d=mm&r=g","caption":"Anne-Marie Dubois"},"url":"https:\/\/dev.inrs.ca\/en\/author\/anne-marie-dubois\/"}]}},"_links":{"self":[{"href":"https:\/\/dev.inrs.ca\/en\/wp-json\/wp\/v2\/posts\/31938","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev.inrs.ca\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dev.inrs.ca\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dev.inrs.ca\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/dev.inrs.ca\/en\/wp-json\/wp\/v2\/comments?post=31938"}],"version-history":[{"count":5,"href":"https:\/\/dev.inrs.ca\/en\/wp-json\/wp\/v2\/posts\/31938\/revisions"}],"predecessor-version":[{"id":31970,"href":"https:\/\/dev.inrs.ca\/en\/wp-json\/wp\/v2\/posts\/31938\/revisions\/31970"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dev.inrs.ca\/en\/wp-json\/wp\/v2\/media\/31955"}],"wp:attachment":[{"href":"https:\/\/dev.inrs.ca\/en\/wp-json\/wp\/v2\/media?parent=31938"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dev.inrs.ca\/en\/wp-json\/wp\/v2\/categories?post=31938"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dev.inrs.ca\/en\/wp-json\/wp\/v2\/tags?post=31938"},{"taxonomy":"sectors","embeddable":true,"href":"https:\/\/dev.inrs.ca\/en\/wp-json\/wp\/v2\/sectors?post=31938"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}